Abstract
Worldwide use of long-acting reversible contraception (LARC) has easily overtaken oral contraceptive use now with double the prevalence.1 Rates of LARC (defined as subdermal implants intrauterine contraceptives and injectables) use are twice as high in the developing world as in the developed world.1 There are many reasons for this increasing use of LARC some to do with potential users and some to do with advocates of LARC. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: BJOG: An International Journal of Obstetrics & Gynaecology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
